scholarly journals No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

2018 ◽  
Vol 9 ◽  
Author(s):  
Ila M. P. Linares ◽  
Francisco S. Guimaraes ◽  
Alan Eckeli ◽  
Ana C. S. Crippa ◽  
Antonio W. Zuardi ◽  
...  
Esophagus ◽  
2017 ◽  
Vol 14 (3) ◽  
pp. 272-273
Author(s):  
Shintaro Hoshino ◽  
Nana Takenouchi ◽  
Yuriko Hanada ◽  
Mariko Umezawa ◽  
Hirohito Sano ◽  
...  

Esophagus ◽  
2016 ◽  
Vol 14 (2) ◽  
pp. 146-152 ◽  
Author(s):  
Shintaro Hoshino ◽  
Nana Takenouchi ◽  
Yuriko Hanada ◽  
Mariko Umezawa ◽  
Hirohito Sano ◽  
...  

Author(s):  
Jocelyn Y. Cheng ◽  
Margaret Moline ◽  
Gary K. Zammit ◽  
Gleb Filippov ◽  
Mohammad Bsharat ◽  
...  

Pain Medicine ◽  
2021 ◽  
Author(s):  
H J (Hemme) Hijma ◽  
P S (Pieter) Siebenga ◽  
M L (Marieke) de Kam ◽  
G J (Geert Jan) Groeneveld

Abstract Objective To evaluate the analgesic potential, safety, tolerability and pharmacokinetics of VX-150, a pro-drug of a highly selective NaV1.8 inhibitor, in healthy subjects. Design This was a randomized, double-blind, placebo-controlled, crossover study in healthy subjects. Subjects Twenty healthy male subjects with an age of 18-55, inclusive, were enrolled. Eligibility was based on general fitness, absence of current or previous medical conditions that could compromise subject safety and a training assessment of pain tolerance across pain tests, to exclude highly tolerant individuals that could compromise the ability to detect analgesic responses. All dosed subjects completed the study. Methods Subjects were randomized 1:1 to 1 of 2 sequences receiving a single VX-150 dose and subsequently placebo, or vice versa, with at least 7 days between dosing. A battery of pain tests (pressure, electrical stair, (capsaicin-induced) heat and cold pressor) was administered pre-dose and repetitively up to 10 h post-dose, with blood sampling up to 24 h post-dose. Safety was monitored throughout the study. Data were analyzed with a repeated measures mixed-effects model. Results VX-150 induced analgesia in a variety of evoked pain tests, without affecting subject safety. Significant effects were reported for cold pressor and heat pain thresholds. Maximum median concentration for the active moiety was 4.30 ug/mL at 4 h post-dose. Conclusion Results of this proof-of-mechanism study are supportive of the potential of VX-150, a highly selective NaV1.8 channel inhibitor, to treat various pain indications.


2017 ◽  
Vol 33 (4) ◽  
pp. 737-744 ◽  
Author(s):  
Fabiana Sarilho de Mendonça ◽  
Paulo de Tarso Camillo de Carvalho ◽  
Daniela Aparecida Biasotto-Gonzalez ◽  
Simone Aparecida Penimpedo Calamita ◽  
Cid André Fidelis de Paula Gomes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document